首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1533630

分子診斷市場規模、佔有率和成長分析：按產品/服務、技術、測試類型和地區 - 產業預測，2024-2031 年

Molecular Diagnostics Market Size, Share, Growth Analysis, By Product & Service (Reagents & Kits, Services & Software), By Technology (PCR, INAAT), By Test Type (Lab Tests PoC Tests), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球分子診斷市場規模將為140億美元，從2023年的156億美元成長到2031年的370億美元，預測期間（2024-2031年）複合年成長率為11.4%。

由於技術進步、新診斷工具的市場開拓、感染疾病案例數量的增加、個人化醫療的使用增加等，全球分子診斷市場提供了巨大的成長機會。分子診斷涉及與疾病相關的生物分子的檢測和表徵，例如遺傳標記、蛋白質和其他分析物。該領域涵蓋廣泛的應用領域，包括感染疾病、腫瘤學、遺傳疾病和藥物基因組學。最近的技術進步引入了 PCR、NGS 和微陣列等創新技術，以提高診斷測試的敏感度和特異性。這些進步提高了多重檢測能力，從而實現更快、更準確的疾病診斷。市場正在顯著擴大，特別是隨著愛滋病毒、肝炎和呼吸道感染疾病等感染疾病率的增加。此外，世界人口老化以及癌症和遺傳疾病等慢性病的日益流行，凸顯了對有效分子診斷工具進行早期檢測和標靶治療的需求。全球分子診斷市場的主要企業包括 Abbott Laboratories、F. Hoffmann-La Roche AG、Danaher Corporation、Qiagen NV 和 Thermo Fisher Scientific Inc.。這些公司正在積極推行併購、新產品發布和策略聯盟等成長策略，以加強其市場佔有率並擴大其產品陣容。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

F. Hoffmann-La Roche Ltd.（Switzerland）
Hologic, Inc.（US）
Abbott Laboratories（US）
Illumina, Inc.（US）
Thermo Fisher Scientific Inc.（US）
bioMerieux（France）
QIAGEN（Netherlands）
Agilent Technologies Inc.（US）
Becton Dickinson And Company（US）
Grifols SA（Spain）
Siemens AG（Siemens Healthineers）（Germany）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
Quidel Corporation（US）
Biocartis（Belgium）
DiaSorin（Italy）
Myriad Genetics（US）
Revvity（US）
MDxHealth（Belgium）
OncoCyte Corporation（US）

簡介目錄

Product Code: SQMIG35A2636

Global Molecular Diagnostics Market size was valued at USD 14.00 billion in 2022 and is poised to grow from USD 15.60 billion in 2023 to USD 37.00 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).

The global molecular diagnostics market presents substantial growth opportunities driven by advancements in technology, the development of new diagnostic tools, the rise in infectious disease cases, and the increasing use of personalized medicine. Molecular diagnostics involve detecting and characterizing disease-related biomolecules, such as genetic markers, proteins, and other analytes. This field encompasses a wide range of applications, including infectious diseases, oncology, genetic disorders, and pharmacogenomics. Recent technological progress has introduced innovations such as PCR, NGS, and microarrays, enhancing the sensitivity and specificity of diagnostic tests. These advancements have improved multiplexing capabilities, leading to quicker and more accurate disease diagnosis. The market is expanding significantly, particularly with the growing incidence of infectious diseases like HIV, hepatitis, and respiratory infections. Additionally, the aging global population and the increasing prevalence of chronic conditions such as cancer and genetic disorders highlight the need for effective molecular diagnostic tools for early detection and targeted treatment. Key players in the global molecular diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche AG, Danaher Corporation, Qiagen N.V., and Thermo Fisher Scientific Inc. These companies are actively pursuing growth strategies such as mergers and acquisitions, new product launches, and strategic partnerships to strengthen their market presence and broaden their product offerings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Diagnostics Market Segmental Analysis

The global molecular diagnostics market is segmented by Product & Service, Test Type, Sample Type, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into reagents & kits, instruments, and services & software. Based on Test Type, the market is segmented into Lab Tests, and PoC Tests. Based on Sample Type, the market is segmented into Blood, Serum, & Plasma, Urine, and Others. Based on Technology, the market is segmented into Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next- Generation Sequencing, In Situ Hybridization, DNA Microarrays, and Others. Based on Application, the market is segmented into Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, and Others. Based on Infectious Disease, the market is segmented into Hepatitis, HIV, CT/NG, HAI, HPV, Tuberculosis, Influenza, and Other Infectious Diseases. Based on Oncology Testing, the market is segmented into Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Other Cancers. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Molecular Diagnostics Market

The rising incidence of infectious diseases such as HIV/AIDS, Hepatitis B and C, and Tuberculosis, alongside the increasing prevalence of genetic disorders, has amplified the demand for molecular diagnostics. Techniques like PCR and other molecular diagnostic methods enable precise and sensitive detection of pathogens. These technologies facilitate timely management and treatment of diseases and support the provision of personalized or individualized care.

Restraints in the Global Molecular Diagnostics Market

Despite their high accuracy and effectiveness, molecular diagnostic tests often come with substantial costs, making them inaccessible in many developing regions with limited healthcare budgets. The expense of molecular testing equipment, the necessary chemicals, and the skilled personnel required for these tests can place a significant financial burden on healthcare facilities. This high cost factor acts as a constraint on the growth of the molecular diagnostics market, particularly in less affluent areas.

Market Trends of the Global Molecular Diagnostics Market

The rise in point-of-care molecular testing is fueled by the demand for swift diagnosis and ongoing treatment monitoring across diverse healthcare environments, such as clinics, emergency rooms, and ambulances. The development of miniaturized and portable molecular diagnostic devices is making real-time testing feasible outside traditional laboratory settings, thereby improving patient care and increasing healthcare efficiency.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Technology Analysis
Regulatory Analysis
Patent Analysis
Value Chain Analysis
Trade Analysis
Case Study Analysis
Pricing Analysis
Supply Chain Analysis
PESTLE Analysis
Top Investment Pockets
Market Attractiveness Index
Market Ecosystem

Molecular Diagnostics Market by Product & Service

Market Overview
Reagents & Kits
Instruments
Services & Software

Molecular Diagnostics Market by Test Type

Market Overview
Lab Tests
PoC Tests

Molecular Diagnostics Market by Sample Type

Market Overview
Blood, Serum, and Plasma
Urine
Others

Molecular Diagnostics Market by Technology

Market Overview
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next- generation Sequencing
In Situ Hybridization
DNA Microarrays
Others

Molecular Diagnostics Market by Application

Market Overview
Infectious Disease Diagnostics
- Hepatitis
- HIV
- CT/NG
- HAI
- HPV
- Tuberculosis
- Influenza
- Other Infectious Diseases
Oncology Testing
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
Genetic Testing
COVID-19
Other Applications

Molecular Diagnostics Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Molecular Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG (Siemens Healthineers) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocartis (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MDxHealth (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OncoCyte Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments